No Data
Jointown Pharmaceutical Group (SHSE:600998) Has Some Way To Go To Become A Multi-Bagger
Jointown Pharmaceutical Group (SHSE:600998) Has A Pretty Healthy Balance Sheet
Jointown Pharmaceutical Group (600998.SH): During this year's november 11 shopping festival-related event, the company's B2C e-commerce general agency sales revenue exceeded 0.216 billion yuan.
Kelonghui November 21st | Jointown Pharmaceutical Group (600998.SH) stated on the interactive platform that the company's B2C e-commerce general agent sales business mainly provides full-scenario services such as e-commerce operation, channel expansion, and supply chain management for pharmaceutical companies and e-commerce platforms, helping pharmaceutical companies achieve growth in online channel business through the integrated mode of "supply chain + operation + digitalization + medical services". As of the end of the third quarter of 2024, the company has distributed and operated over 40 well-known pharmaceutical and health brands' official flagship stores online, including 5 projects with over 100 million yuan in operation and over 20 projects with over 10 million yuan in operation. In the first three quarters of 2024, the company
Jointown Pharmaceutical Group (600998.SH) plans to carry out the filing and fundraising of pre-REITs funds for medical logistics warehousing.
Jointown Pharmaceutical Group (600998.SH) announced that, in order to further optimize assets structure and improve capital operation efficiency, the company...
Jointown Pharmaceutical Group (600998.SH): Intends to invest 0.245 billion yuan to establish the Jiuying Entrepreneurship Investment Fund.
Gelonghui, November 8th: Jointown Pharmaceutical Group (600998.SH) announced that, guaranteeing the necessary funds for daily operation, Jointown Pharmaceutical Group plans to jointly invest with Chuchang private equity fund to establish Wuhan Jiuying Entrepreneurship Investment Fund Partnership Enterprise (Limited Partnership) (tentatively named, subject to industrial and commercial approval, hereinafter referred to as "Jiuying Entrepreneurship Investment Fund"), with a planned total fundraising scale of 0.5 billion yuan. Among them, Jointown Pharmaceutical Group as a limited partner intends to subscribe for 0.245 billion yuan, with a subscription ratio not exceeding 49%; Chuchang private equity fund as a general partner and executive partner intends to subscribe for 5 million yuan.
Jointown Pharmaceutical Group (600998.SH): has repurchased 1.11% of the shares accumulated.
Gelonghui November 4th | Jointown Pharmaceutical Group (600998.SH) announced that as of October 31, 2024, the company has repurchased a total of 56.0365 million shares of stocks, accounting for 1.11% of the total share capital of the company. The highest purchase price was 5.49 yuan/share, and the lowest price was 4.42 yuan/share. The total amount paid was 268.0977 million yuan (excluding commissions and fees).
Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Shares Lagging The Market But So Is The Business
No Data
